Excelsior Medical Valuation
| 4104 Stock | TWD 87.40 0.40 0.46% |
At this time, the firm appears to be fairly valued. Excelsior Medical shows a prevailing Real Value of NT$87.38 per share. The current price of the firm is NT$87.4. Our model computes the value of Excelsior Medical from reviewing the firm fundamentals such as Operating Margin of 0.08 %, profit margin of 0.1 %, and Current Valuation of 7.28 B as well as analyzing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Excelsior Medical's price fluctuation is very steady at this time. Calculation of the real value of Excelsior Medical is based on 3 months time horizon. Increasing Excelsior Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Excelsior stock is determined by what a typical buyer is willing to pay for full or partial control of Excelsior Medical Co. Since Excelsior Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Excelsior Stock. However, Excelsior Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 87.4 | Real 87.38 | Hype 87.4 |
The intrinsic value of Excelsior Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Excelsior Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Excelsior Medical Co helps investors to forecast how Excelsior stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Excelsior Medical more accurately as focusing exclusively on Excelsior Medical's fundamentals will not take into account other important factors: Excelsior Medical Total Value Analysis
Excelsior Medical Co is presently anticipated to have takeover price of 7.28 B with market capitalization of 11.19 B, debt of 705.38 M, and cash on hands of 3.9 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Excelsior Medical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
7.28 B | 11.19 B | 705.38 M | 3.9 B |
Excelsior Medical Investor Information
About 40.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.2. In the past many companies with similar price-to-book ratios have beat the market. Excelsior Medical last dividend was issued on the 13th of July 2022. The entity had 1000:1050 split on the 26th of August 2024. Based on the analysis of Excelsior Medical's profitability, liquidity, and operating efficiency, Excelsior Medical Co is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Excelsior Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Excelsior Medical has an asset utilization ratio of 43.52 percent. This indicates that the Company is making NT$0.44 for each dollar of assets. An increasing asset utilization means that Excelsior Medical Co is more efficient with each dollar of assets it utilizes for everyday operations.Excelsior Medical Ownership Allocation
Excelsior Medical holds a total of 148.21 Million outstanding shares. Excelsior Medical Co retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Excelsior Medical Profitability Analysis
The company reported the revenue of 6.57 B. Net Income was 607.15 M with profit before overhead, payroll, taxes, and interest of 1.37 B.About Excelsior Medical Valuation
Our relative valuation model uses a comparative analysis of Excelsior Medical. We calculate exposure to Excelsior Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Excelsior Medical's related companies.Excelsior Medical Co., Ltd. distributes medical related systems in Taiwan, China, Japan, Korea, Malaysia, and the Philippines. The company was founded in 1988 and is based in New Taipei City, Taiwan. EXCELSIOR MEDICAL operates under Medical Devices classification in Taiwan and is traded on Taiwan Stock Exchange.
8 Steps to conduct Excelsior Medical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Excelsior Medical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Excelsior Medical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Excelsior Medical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Excelsior Medical's revenue streams: Identify Excelsior Medical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Excelsior Medical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Excelsior Medical's growth potential: Evaluate Excelsior Medical's management, business model, and growth potential.
- Determine Excelsior Medical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Excelsior Medical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Excelsior Stock Analysis
When running Excelsior Medical's price analysis, check to measure Excelsior Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Excelsior Medical is operating at the current time. Most of Excelsior Medical's value examination focuses on studying past and present price action to predict the probability of Excelsior Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Excelsior Medical's price. Additionally, you may evaluate how the addition of Excelsior Medical to your portfolios can decrease your overall portfolio volatility.